Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival

Microsurgery

Volumn 23, Issue 4, 2003, Pages 374-380

  Jung, Howard ^a   Gurunluoglu, Raffi ^a   Scharpf, Joe ^a   Siemionow, Maria ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; GENE PRODUCT; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; GENE AMPLIFICATION; GENE THERAPY; GRAFT SURVIVAL; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP; SKIN NECROSIS; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANGIOPOIETIN-1; ANIMALS; GENE THERAPY; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SURGICAL FLAPS;

EID: 0041832142     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.10140     Document Type: Article

References (24)

1. Pellitteri PK, Kennedy TL, Youn BA. The influence of intensive hyperbaric oxygen therapy on skin flap survival in a swine model. Arch Otolaryngol Head Neck Surg 1992;118:1050-1054.
2. Hom DB, Baker SR, Graham LM, McClatchey KD. Utilizing angiogenic agents to expedite the neovascularization process in skin flaps. Laryngoscope 1988;98:521-526.
3. Im MJ, Kim YS, Edwards RJ, Hoopes JE, Fenselau A. The effect of bovine basic fibroblast growth factor on skin flap survival in rats. Ann Plast Surg 1992;28:242-245.
4. Ishiguro N, Yabe Y, Shimzu T, Iwata H, Miura T. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg 1994;32:356-360.
5. Khouri RK, Brown DM, Leal-Khouri SM, Tark KC, Shaw WW. The effect of basic fibroblast growth factor on the neovascularization process: skin flap survival and staged flap transfers, Br J Plast Surg 1991;44:585-588.
6. Padubidri A, Brown E Jr. Effect of vascular endothelial growth factor on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 1996;37:604-611.
7. Uhl E, Barker JH, Bondar I, Galla TJ, Lehr HA, Messmer K. Improvement of skin flap perfusion by subdermal injection of recombinant human basic fibroblast growth factor. Ann Plast Surg 1994;32:361-366.
8. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-1180.
9. Kim I, Kim H, So J, Kim J, Kwak H, Koh G. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res 2000;86:24-29.
10. Kim I, Kim H, Moon S, Chae S, So J, Koh K, Ahn B, Koh G. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 2000;86:952-959.
11. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999;286:2511-2514.
12. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000;97:603-607.
13. Thurston G, Rudge JS, Ioffe E, Zhou H, Mahon S, Glazer N, McDonald DM, Yancouplos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6:460-463.
14. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997;81:567-574.
15. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 2000;275:9102-9105.
16. Shyu K, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998;98:2081-2087.
17. Lubiatowski P, Goldman CK, Gurunlouoglu R, Carnevale K, Siemienow M. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 2002;110:149-159.
18. Padubidri AN, Browne E Jr. Modification in flap design of the epigastric artery flap in rats-a new experimental flap model. Ann Plast Surg 1997;39:500.
19. William C, Koehne P, Jurgensen JS, Grafe M, Wagner KD, Bachmann S, Frei U, Eckardt K. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res 2000;87:370-377.
20. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000;355:213-222.
21. Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemienow M. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Ann Plast Surg 2002;49:161-169.
22. Kampfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001;81:361-373.
23. Lubiatowski P, Gurunluoglu R, Goldman CK, Skugor B, Carnevale K, Siemionow M. Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast Reconstr Surg 2002;110:149-159.
24. Chae J, Kim I, Lim S, Chung M, Kim W, Kim H, Ko J, Koh G. Coadministration of angiopoietin-1 and vascular cndothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 2000;20:2573-2578.